Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-103247
Filing Date
2021-04-01
Accepted
2021-04-01 07:38:59
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A d156620ddefa14a.htm DEFA14A 30902
2 GRAPHIC g156620naa0003.jpg GRAPHIC 1257
3 GRAPHIC g156620naa0004.jpg GRAPHIC 913
4 GRAPHIC g156620naa0005.jpg GRAPHIC 873
5 GRAPHIC g156620naa0006.jpg GRAPHIC 1152
6 GRAPHIC g156620naaa02.jpg GRAPHIC 1258
7 GRAPHIC g156620pc0001.jpg GRAPHIC 2030
  Complete submission text file 0001193125-21-103247.txt   43080
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39335 | Film No.: 21796040
SIC: 2834 Pharmaceutical Preparations